Atezolizumab vs Insulin Glargine

## Atezolizumab vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Insulin Glargine**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Insulin Glargine — 12-24 hours.

## Chemical Properties

**Type**: Atezolizumab — Antibody; Insulin Glargine — Protein.